BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Prognosis
25 results:

  • 1. LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression.
    Chen W; Wang F; Yu X; Qi J; Dong H; Cui B; Zhang Q; Wu Y; An J; Ni N; Liu C; Han Y; Zhang S; Schmitt CA; Deng J; Yu Y; Du J
    Oncogene; 2024 May; 43(18):1328-1340. PubMed ID: 37950038
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis.
    Xiang X; Kuang W; Yu C; Li Y; Su Q; Tian Y; Li J
    Mol Carcinog; 2023 Dec; 62(12):1974-1989. PubMed ID: 37792308
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrative analysis of lactylation-related genes and establishment of a novel prognostic signature for hepatocellular carcinoma.
    Cai D; Yuan X; Cai DQ; Li A; Yang S; Yang W; Duan J; Zhuo W; Min J; Peng L; Wei J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11517-11530. PubMed ID: 37400571
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EGR1 induces EMT in pancreatic cancer via a p300/SNAI2 pathway.
    Wang Y; Qin C; Zhao B; Li Z; Li T; Yang X; Zhao Y; Wang W
    J Transl Med; 2023 Mar; 21(1):201. PubMed ID: 36932397
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin.
    Meng J; Han J; Wang X; Wu T; Zhang H; An H; Qin L; Sun Y; Zhong W; Yang C; Liu H; Sun T
    Pharmacol Res; 2023 Feb; 188():106661. PubMed ID: 36669583
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
    Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
    Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.
    Liu YC; Lin YH; Chi HC; Huang PS; Liao CJ; Liou YS; Lin CC; Yu CJ; Yeh CT; Huang YH; Lin KH
    Clin Epigenetics; 2022 Aug; 14(1):106. PubMed ID: 35999564
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.
    Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
    Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of bromodomain-containing protein 4 (BRD4) and intestine-specific homeobox (ISX) expression on the prognosis of patients with hepatocellular carcinoma' for better clarity.
    Chuang KT; Wang SN; Hsu SH; Wang LT
    Cancer Med; 2021 Aug; 10(16):5545-5556. PubMed ID: 34173348
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B-related hepatocellular carcinoma.
    Chai X; Guo J; Dong R; Yang X; Deng C; Wei C; Xu J; Han W; Lu J; Gao C; Gao D; Huang C; Ke A; Li S; Li H; Tian Y; Gu Z; Liu S; Liu H; Chen Q; Liu F; Zhou J; Fan J; Shi G; Wu F; Cai J
    Clin Transl Med; 2021 Mar; 11(3):e313. PubMed ID: 33783990
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in liver cancer.
    Hong SH; Son KH; Ha SY; Wee TI; Choi SK; Won JE; Han HD; Ro Y; Park YM; Eun JW; Nam SW; Han JW; Kang K; You JS
    Cancer Res; 2021 Jan; 81(2):356-370. PubMed ID: 33239431
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Development and external validation of a nomogram for predicting the effect of tumor size on survival of patients with perihilar cholangiocarcinoma.
    Zhang Y; Wu Z; Wang X; Li C; Chang J; Jiang W; Wang H; Wang Y; Li X
    BMC Cancer; 2020 Oct; 20(1):1044. PubMed ID: 33126868
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.
    Zheng Y; Wu C; Yang J; Zhao Y; Jia H; Xue M; Xu D; Yang F; Fu D; Wang C; Hu B; Zhang Z; Li T; Yan S; Wang X; Nelson PJ; Bruns C; Qin L; Dong Q
    Signal Transduct Target Ther; 2020 May; 5(1):53. PubMed ID: 32398667
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Upregulation of GPNCA is associated with poor prognosis through enhancement of tumor growth via regulating GSK3B.
    Liao W; Liu F; Zhang H; Liao W; Xu N; Xie W; Zhang Y
    Sci Rep; 2020 Feb; 10(1):2044. PubMed ID: 32029792
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. METTL3-mediated m
    Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
    Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma.
    Tsang FH; Law CT; Tang TC; Cheng CL; Chin DW; Tam WV; Wei L; Wong CC; Ng IO; Wong CM
    Hepatology; 2019 Jun; 69(6):2502-2517. PubMed ID: 30723918
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.
    Bian XL; Chen HZ; Yang PB; Li YP; Zhang FN; Zhang JY; Wang WJ; Zhao WX; Zhang S; Chen QT; Zheng Y; Sun XY; Wang XM; Chien KY; Wu Q
    Nat Commun; 2017 Feb; 8():14420. PubMed ID: 28240261
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
    Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
    FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling.
    Zhang L; Ge C; Zhao F; Zhang Y; Wang X; Yao M; Li J
    Cancer Res; 2016 Dec; 76(23):7059-7071. PubMed ID: 27634758
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.
    Li H; An J; Wu M; Zheng Q; Gui X; Li T; Pu H; Lu D
    Oncotarget; 2015 Sep; 6(29):27847-64. PubMed ID: 26172293
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.